Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| NOMA | Nomadar | $10.04 | -$10.96 | -52.19% | 242.6K | - | $2.00$57.70 |
| QURE | uniQure | $34.07 | -$33.62 | -49.67% | 29.1M | $4.2B | $5.35$71.50 |
| CURR | Currenc Group | $2.22 | -$1.56 | -41.21% | 31.1M | $287.6M | $0.33$7.08 |
| ALVO | Alvotech | $5.03 | -$2.62 | -34.25% | 157.9K | $2.3B | $4.82$13.70 |
| CMBM | Cambium Networks | $2.07 | -$0.92 | -30.77% | 6.8M | $84.4M | $0.23$6.80 |
| SOC | Sable Offshore | $7.25 | -$3.21 | -30.73% | 14.4M | $1.0B | $6.79$35.00 |
| NCEL | NewcelX | $5.37 | -$1.92 | -26.35% | 385.4K | $31.0M | $4.20$47.40 |
| HKD | AMTD Digital | $2.20 | -$0.75 | -25.43% | 10.9M | $241.9M | $1.55$5.47 |
| SOLT | Volatility Shares Trust - 2x Solana ETF | $12.92 | -$4.34 | -25.14% | 18.6M | - | $7.74$35.30 |
| NVA | Nova Minerals | $6.86 | -$2.08 | -23.24% | 2M | $61.1M | $1.40$16.28 |
Related Articles
Featured Article
This Small AI Stock Has Outpaced Nvidia. 1 Reason Why It's Still Rising.
Stefon Walters|Oct 22, 2025
This company's path to profitability is getting a lot clearer.
Up 152% in December, Is uniQure a Good Stock to Buy Now and Hold Through 2025?
Cory Renauer|Dec 15, 2024
3 Stocks to Avoid This Week
Rick Munarriz|Aug 8, 2022
These investments seem pretty vulnerable right now.
Is It Too Late to Buy AMTD Digital Stock?
Leo Sun|Aug 5, 2022
This fintech stock has suddenly become the next GameStop.
Late-Stage Clinical Study Readouts Biotech Investors Should Watch
Keith Speights and Brian Orelli, PhD|Jul 11, 2021
Several drugmakers have important clinical trial updates on the way.
uniQure Inks $2 Billion Licensing Deal With CSL Behring
Todd Campbell|Jun 25, 2020
Agreement licenses the rights for a promising hemophilia B gene therapy.
Cummins and DuPont Partner to Make N95 Mask Alternative
Neha Chamaria|Apr 6, 2020
Cummins has made N95 mask prototypes combining its filtration technology with DuPont's to address mask shortages in the wake of the COVID-19 pandemic.
3 Stocks That Could Be the Next Biotech Buyouts
Cory Renauer|Dec 23, 2019
Here are the biotechs most likely to receive juicy buyout offers in 2020.
Don't Get Too Excited About Cambium Networks' Recent IPO
Billy Duberstein|Jul 9, 2019
New IPOs can be exciting, but investors should steer clear of Cambium for now.
